| ‘Pure’invasive apocrine carcinoma of the breast: a new clinicopathological entity? H Japaze, J Emina, C Diaz, RJ Schwam, N Gercovich, G Demonty, ... The Breast 14 (1), 3-10, 2005 | 109 | 2005 |
| TNFα-induced mucin 4 expression elicits trastuzumab resistance in HER2-positive breast cancer MF Mercogliano, M De Martino, L Venturutti, MA Rivas, CJ Proietti, ... Clinical Cancer Research 23 (3), 636-648, 2017 | 105 | 2017 |
| p42/p44 MAPK-mediated Stat3 Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth M Tkach, C Rosemblit, MA Rivas, CJ Proietti Anastasi, MC Díaz Flaqué, ... Bioscientifica, 2013 | 99 | 2013 |
| Colorectal carcinoma in children, adolescents, and young adults GL Chantada, VB Perelli, MG Lombardi, D Amaral, D Cascallar, ... Journal of pediatric hematology/oncology 27 (1), 39-41, 2005 | 80 | 2005 |
| Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer MF Mercogliano, G Inurrigarro, M De Martino, L Venturutti, MA Rivas, ... BMC cancer 17, 1-8, 2017 | 23 | 2017 |
| Phase III study of navelbine vs. navelbine plus cisplatin in non small cell lung cancer stage IIIB or IV E Gil Deza Proc ASCO 15, 394, 1996 | 23 | 1996 |
| Synchronous and metachronous second (ST) and third (TT) primary tumors (PT) in a large patient population EL Morgenfeld, GF Tognelli, E Deza, D Santillan, S Ares, E Morgenfeld Proc ASCO 22, 3152, 2003 | 16 | 2003 |
| Multiple primary cancer in adults (MPCA) SL Ares, S Polo, L Ezcurdia, F Tognelli, S Mussini, N Gercovich, ... Journal of Clinical Oncology 24 (18_suppl), 16027-16027, 2006 | 11 | 2006 |
| Navelbine (N) plus adriamycin (A) vs FAC in advanced breast cancer C Blajman, L Balbiani, J Block, R Bianchi, G Temperley, R Chacon, ... Proc ASCO 12, 92, 1993 | 10 | 1993 |
| Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression S Bruni, FL Mauro, CJ Proietti, RI Cordo-Russo, MA Rivas, G Inurrigarro, ... Journal for Immunotherapy of Cancer 11 (3), 2023 | 9 | 2023 |
| Nuclear PDCD4 expression defines a subset of luminal B-like breast cancers with good prognosis S Madera, MF Chervo, VA Chiauzzi, MG Pereyra, L Venturutti, F Izzo, ... Hormones and Cancer 11 (5), 218-239, 2020 | 9 | 2020 |
| Rol del distrés psicológico en la relación entre percepción de enfermedad y calidad de vida en pacientes con cáncer de mama D Gercovich, PL López, D Bortolato, P Margiolakis, M Morgenfeld, ... Psicooncologia 9 (2/3), 403, 2012 | 8 | 2012 |
| Psicoterapia focalizada en pacientes oncológicos. Resultados del tratamiento en un contexto naturalístico D Gercovich, F Torrente, P López, P Margiolakis, D Bortolato, H Hirsch, ... Revista Argentina de Clínica Psicológica 20 (3), 239-246, 2011 | 5 | 2011 |
| Expanded access program single agent oxaliplatin in fluoropyrimidine resistant advanced colorectal cancer patients A Schmilovich, R Chacon, F Coppola, E Michiewiecz, C Blajman, J Block, ... PROCEEDINGS OF THE ANNUAL MEETING-AMERICAN SOCIETY OF CLINICAL ONCOLOGY 17 …, 1998 | 5 | 1998 |
| Vinorelbine (VNB) containing regimens in three different schedules for the treatment of advanced breast cancer (ABC) F Coppola, L Balbiani, C Blajman, P Vilanova, S Bonicatto, C Rufino, ... Proc Am Soc Clin Oncol 13, 85, 1994 | 5 | 1994 |
| Evaluación de las necesidades de los pacientes respecto a la información y los cuidados médicos tras el diagnóstico de cáncer EG Deza, D Gercovich, E Morgenfeld, F Tognelli, GM Reinas, P López, ... Psicooncología: investigación y clínica biopsicosocial en oncología 11 (2 …, 2014 | 4 | 2014 |
| Abstract P5-13-32: mucin 4 expression in high risk breast cancer: predicting and overcoming resistance to immunotherapy R Schillaci, S Bruni, F Mauro, MF Mercogliano, A Roldan-Deamicis, ... Cancer Research 82 (4_Supplement), P5-13-32-P5-13-32, 2022 | 2 | 2022 |
| Incidental vs. clinical diagnosis of renal cell carcinoma (RCC): Population, treatment and outcome in a cohort of 828 patients followed at Instituto Oncológico Henry Moore (IOHM). D Niewiadomski, CL Acuna, EL Morgenfeld, F Tognelli, L Smolje, ... Journal of Clinical Oncology 35 (15_suppl), e16075-e16075, 2017 | 2 | 2017 |
| Polypharmacy in oncology patients. E Gil Deza, EL Morgenfeld, EGJ Rivarola, G Martin Reinas, N Kohen, ... Journal of Clinical Oncology 32 (15_suppl), e17582-e17582, 2014 | 2 | 2014 |
| Human resources allocation in oncologic day hospital: Validation of the Kohen-Gil Deza scale (KGD) for risk assesment. N Kohen, E Gil Deza, N Gercovich, EL Morgenfeld, CF Garcia Gerardi, ... Journal of Clinical Oncology 31 (15_suppl), 6596-6596, 2013 | 2 | 2013 |
